AbstractCachexia, a paraneoplastic syndrome markedly associated with worsened prognosis in cancer patients, provokes profound wasting of both lean and adipose mass in an association with a state of metabolic “chaos”. The white adipose tissue responds to cachexia with marked local inflammation and may be thus a relevant contributor to systemic inflammation. To address this hypothesis we examined the correlation between tissue expression of adipokines and plasma concentration in cachectic and stable weight patients with or without cancer. Adiponectin and liver-derived CRP concentration were significantly higher in the cachectic groups when compared with stable weight patients (P<0.01). The concentration of plasma IL-6 was higher (11.4-fold) i...
Cancer cachexia is an unmet clinical need that affects more than 50% of patients with cancer. The sy...
Abstract Background Cancer cachexia is a progressive and multi-factorial metabolic syndrome characte...
Weight loss is diagnostic of cachexia, a debilitating syndrome contributing mightily to morbidity an...
AbstractCachexia, a paraneoplastic syndrome markedly associated with worsened prognosis in cancer pa...
Abstract Background Cancer cachexia (CC) is a multifactorial syndrome, often irreversible, that affe...
Cancer cachexia is a complex disorder that is driven by inflammation and metabolic imbalances, resul...
Background and aims: Cachexia is a syndrome characterized by marked involuntary loss of body weight....
Background: During cancer cachexia, several alterations occur in peripheral tissues, and the adipose...
Extensive loss of adipose tissue is a hallmark of cancer cachexia but the cellular and molecular bas...
Cancer-associated wasting, termed cancer cachexia, has a profound effect on the morbidity and mortal...
Abstract\ud \ud Background\ud Cancer cachexia is a mul...
Traditionally, skeletal muscle and adipose tissue have been the focus of research on cancer cachexi...
Background Cancer cachexia is a poorly understood metabolic consequence of cancer. During cachexia, ...
Simple Summary Cachexia occurs frequently in cancer patients with deep metabolic derangements. The b...
Cancer cachexia is a multifaceted syndrome whose aetiology is extremely complex and is directly rela...
Cancer cachexia is an unmet clinical need that affects more than 50% of patients with cancer. The sy...
Abstract Background Cancer cachexia is a progressive and multi-factorial metabolic syndrome characte...
Weight loss is diagnostic of cachexia, a debilitating syndrome contributing mightily to morbidity an...
AbstractCachexia, a paraneoplastic syndrome markedly associated with worsened prognosis in cancer pa...
Abstract Background Cancer cachexia (CC) is a multifactorial syndrome, often irreversible, that affe...
Cancer cachexia is a complex disorder that is driven by inflammation and metabolic imbalances, resul...
Background and aims: Cachexia is a syndrome characterized by marked involuntary loss of body weight....
Background: During cancer cachexia, several alterations occur in peripheral tissues, and the adipose...
Extensive loss of adipose tissue is a hallmark of cancer cachexia but the cellular and molecular bas...
Cancer-associated wasting, termed cancer cachexia, has a profound effect on the morbidity and mortal...
Abstract\ud \ud Background\ud Cancer cachexia is a mul...
Traditionally, skeletal muscle and adipose tissue have been the focus of research on cancer cachexi...
Background Cancer cachexia is a poorly understood metabolic consequence of cancer. During cachexia, ...
Simple Summary Cachexia occurs frequently in cancer patients with deep metabolic derangements. The b...
Cancer cachexia is a multifaceted syndrome whose aetiology is extremely complex and is directly rela...
Cancer cachexia is an unmet clinical need that affects more than 50% of patients with cancer. The sy...
Abstract Background Cancer cachexia is a progressive and multi-factorial metabolic syndrome characte...
Weight loss is diagnostic of cachexia, a debilitating syndrome contributing mightily to morbidity an...